• Aucun résultat trouvé

[PDF] Top 20 Pretreatment thrombocytosis : A prognostic marker for oral squamous cell carcinoma?

Has 10000 "Pretreatment thrombocytosis : A prognostic marker for oral squamous cell carcinoma?" found on our website. Below are the top 20 most common "Pretreatment thrombocytosis : A prognostic marker for oral squamous cell carcinoma?".

Pretreatment thrombocytosis : A prognostic marker for oral squamous cell carcinoma?

Pretreatment thrombocytosis : A prognostic marker for oral squamous cell carcinoma?

... rate for oral squamous cell carcinoma (SCC) has been virtually unchanged over the past few ...Several prognostic factors—like infiltration depth, metastases, and perineural ... Voir le document complet

4

Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy

Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy

... demonstrate, for the first time, that pre-treatment serum CYFRA 21-1 levels are sig- nificantly correlated with ASCC tumour stage, as previously reported in other cancers [ 4 , 20 , 26 ...tute a potential ... Voir le document complet

9

Evaluation of clinical and histomorphological parameters as potential predictors of occult metastases in sentinel lymph nodes of early squamous cell carcinoma of the oral cavity

Evaluation of clinical and histomorphological parameters as potential predictors of occult metastases in sentinel lymph nodes of early squamous cell carcinoma of the oral cavity

... validated for the treatment of early oral and oropharyngeal SCC by a wide range of validation trials throughout the ...is a more accurate histopathologic staging of the clinically and ... Voir le document complet

9

Is Lymph-node Ratio a Superior Predictor than Lymph Node Status for Recurrence-free and Overall Survival in Patients with Head and Neck Squamous Cell Carcinoma?

Is Lymph-node Ratio a Superior Predictor than Lymph Node Status for Recurrence-free and Overall Survival in Patients with Head and Neck Squamous Cell Carcinoma?

... HNSCC, a more valid prognostic factor for recurrence-free and overall survival than TNM staging system; does this evidence valid for other regions than the oral cavity in HNSCC; and to ... Voir le document complet

7

Diagnostic and prognostic value of circulating tumor cells in head and neck squamous cell carcinoma: a systematic review and meta-analysis

Diagnostic and prognostic value of circulating tumor cells in head and neck squamous cell carcinoma: a systematic review and meta-analysis

... in a peer-reviewed journal; 2) only English language papers were included; 3) to avoid ambiguity in the definition of CTC, only techniques using peripheral blood but not bone marrow or other body fluids of ... Voir le document complet

10

Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients

Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients

... in a cryotube immediately after surgery and stored at − 80 °C, under temperature ...control. A tumor fragment of 5–40 mg and 10–50 mg was used for DNA and RNA extraction, ...on a 4–5 µm ... Voir le document complet

14

A Marker-and-Cell scheme for viscoelastic flows
on nonuniform grids

A Marker-and-Cell scheme for viscoelastic flows on nonuniform grids

... obtain a stationary solution: δ t = 0.001 for the M1, M2 and M3 meshes, and δ t = ...0.0005 for the M4 mesh. With a larger times-step, low-frequency instabilities (period in range of 1s) ... Voir le document complet

10

A Marker-and-Cell scheme for viscoelastic flows on nonuniform grids

A Marker-and-Cell scheme for viscoelastic flows on nonuniform grids

... develop a numerical scheme for the solution of System (1) based on the following ...so-called Marker- And-Cell (MAC) scheme. Previous work on MAC schemes for viscoelastic flows can be ... Voir le document complet

9

Genomic instability : a stronger prognostic marker than proliferation for early stage luminal breast carcinomas

Genomic instability : a stronger prognostic marker than proliferation for early stage luminal breast carcinomas

... to a previously published protocol [27], 94 of the 105 validation cases meeting our selection criteria for node status, tumor size, ER and HER2 status, were hybridized onto U133 plus ...(GGI), a ... Voir le document complet

10

Second primary squamous cell carcinoma arising in cutaneous flap reconstructions of two head and neck cancer patients

Second primary squamous cell carcinoma arising in cutaneous flap reconstructions of two head and neck cancer patients

... with a prior history of squamous cell carcinoma of the head and neck (HNSCC), who developed a second primary SCC on the cutaneous surface of their Xaps, years after recon- ...of ... Voir le document complet

5

O6-Methylguanine-DNA-Methyltransferase methylation: prevalence and predictive value in head and neck squamous cell carcinoma

O6-Methylguanine-DNA-Methyltransferase methylation: prevalence and predictive value in head and neck squamous cell carcinoma

... Il a été démontré qu’une diminution de l’expression du gène MGMT par une hyperméthylation du promoteur résulte en une amélioration de la survie chez les patients avec certains types de tumeurs qui sont traitées ... Voir le document complet

52

Radiation therapy alone or combined surgery and radiation therapy in squamous-cell carcinoma of the penis?

Radiation therapy alone or combined surgery and radiation therapy in squamous-cell carcinoma of the penis?

... penile carcinoma is more frequent in uncircumcised men, poor genital hygiene and human papilloma virus infection ...serving a functional organ in early-stage penile cancers ...the prognostic fac- ... Voir le document complet

6

Head and neck squamous cell carcinoma (HNSCC) - detection of synchronous primaries with 18F-FDG-PET/CT

Head and neck squamous cell carcinoma (HNSCC) - detection of synchronous primaries with 18F-FDG-PET/CT

... still a matter of controversy as to how FDG-PET/CT should be integrated into the staging algorithm of patients with HNSCC [ 24 ...troublesome for the PET/CT ... Voir le document complet

9

CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.

CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.

... essential for the self renewal of hematopoietic, neuronal stem cells as well as cancer stem/progenitor cells ...co-staining for CTIP2 and BMI1 protein, in well, moderately and poorly differentiated HNSCC ... Voir le document complet

11

The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade

The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade

... with a higher rate of tumor infiltrating T-cells in NSND, including mostly T- cytotoxic CD8 ...play a role during oral carcinogenesis through the inhibition of Langerhans cells maturation, by ... Voir le document complet

27

The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma

The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma

... Results: The mean 3 rd generation/2 nd generation PTH ratio was 0.58±0.10 in the dialysis patients, 0.54±0.10 in the renal transplant group, 0.54±0.12 in the elderly healthy patients and 0.68±0.11 in the PHP group. All ... Voir le document complet

1

Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME

Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME

... The objectives were to assess PFS defined as the time from first injection of PC or P to disease progression, as- sessed clinically or radiologically, or death, OS defined as the time from first injection of PC or P to ... Voir le document complet

13

Sickness absence as a prognostic marker for common chronic conditions: analysis of mortality in the GAZEL study.

Sickness absence as a prognostic marker for common chronic conditions: analysis of mortality in the GAZEL study.

... Mika Kivimaki, Jenny Head, Jane Ferrie, Archana Singh-Manoux, Hugo Westerlund, Jussi Vahtera, Annette Leclerc, Maria Melchior, Anne Chevalier,. Kristina Alexanderson, et al[r] ... Voir le document complet

27

Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction

Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction

... transcripts for the EGFR ligand epiregulin in basal-like HNSCC cells, and reduced their clonogenic ...HNSCC cell lines to EGFR blockade correlates with the expression levels of several EGFR ...reported ... Voir le document complet

18

Differential expression of anti-apoptotic protein Bcl-2 in keratinizing versus non-keratinizing squamous cell carcinoma of the anus

Differential expression of anti-apoptotic protein Bcl-2 in keratinizing versus non-keratinizing squamous cell carcinoma of the anus

... recommend for future clin- ical studies that the histopathological terminology of SCCA should still consider the degree of keratinization in order to identify potential differences in ... Voir le document complet

4

Show all 10000 documents...